# Effect of Nicorandil in Type 2 Diabetic Obese Patients

> **NCT06423729** · PHASE2,PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 46 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Nicorandil 10 MG

## Key facts

- **NCT ID:** NCT06423729
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423729, "Effect of Nicorandil in Type 2 Diabetic Obese Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06423729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*